Updates in Family Medicine from the Internet Medical Association
This study found that both aspirin and COX-2 inhibitors were associated with improved outcomes in stage III colon cancer patients. (J Natl Cancer Inst. 2014 Nov 27;107(1). pii: dju345. Print 2015 Jan.)